1 of 2
Story summary
- Telomir Pharmaceuticals' shares surged 31% to $1.86 after preclinical results for Telomir-1 in prostate cancer models.
- Galecto Inc. stock rose 662.51% to $28.38 on speculative trading.
- U.S. stocks rose, with the Dow Jones Industrial Average up over 100 points.
- McCormick & Co. posted earnings of 85 cents per share, above estimates.
- Redbook retail sales index rose 5.8% YoY for week ending October 4.
1 / 2
